Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gallo

Showing results (451-460 of 471) with videos related to

Pageof 48
Sort By:
Techniques in Coloproctology|March 25, 2022
A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM)G Gallo, R Pietroletti, E Novelli, et al.
The British Journal of Dermatology|April 22, 2020
Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS)A S Paller, M M B Seyger, G Alejandro Magariños, et al.
The British Journal of Dermatology|December 31, 2019
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trialA Blauvelt, K Papp, A Gottlieb, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 16, 2013
A computational future for preventing HIV in minority communities: how advanced technology can improve implementation of effective programsC Hendricks Brown, David C Mohr, Carlos G Gallo, et al.
Administration and Policy in Mental Health|December 14, 2011
Partnerships for the design, conduct, and analysis of effectiveness, and implementation research: experiences of the prevention science and methodology groupC Hendricks Brown, Sheppard G Kellam, Sheila Kaupert, et al.
The British Journal of Dermatology|September 4, 2020
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trialA Blauvelt, C Leonardi, B Elewski, et al.
Techniques in Coloproctology|July 30, 2025
The application of EPSiT in pilonidal sinus disease: an international Delphi consensus study endorsed by the Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI)H K Sekhon Inderjit Singh, P Meinero, F C Campanile, et al.
Techniques in Coloproctology|August 19, 2023
Five-year recurrence after endoscopic approach to pilonidal sinus disease: A multicentre experienceM Manigrasso, A D'Amore, E Benatti, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 4, 2020
Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancerK G P Kerckhoffs, D H W Liu, L Saragoni, et al.
The Review of Scientific Instruments|March 5, 2008
A status report of the multipurpose superconducting electron cyclotron resonance ion sourceG Ciavola, S Gammino, S Barbarino, et al.
Pageof 48

Showing results (451-460 of 471) with videos related to

Sort By:
Pageof 48
Techniques in Coloproctology|March 25, 2022
A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM)G Gallo, R Pietroletti, E Novelli, et al.
The British Journal of Dermatology|April 22, 2020
Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS)A S Paller, M M B Seyger, G Alejandro Magariños, et al.
The British Journal of Dermatology|December 31, 2019
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trialA Blauvelt, K Papp, A Gottlieb, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 16, 2013
A computational future for preventing HIV in minority communities: how advanced technology can improve implementation of effective programsC Hendricks Brown, David C Mohr, Carlos G Gallo, et al.
Administration and Policy in Mental Health|December 14, 2011
Partnerships for the design, conduct, and analysis of effectiveness, and implementation research: experiences of the prevention science and methodology groupC Hendricks Brown, Sheppard G Kellam, Sheila Kaupert, et al.
The British Journal of Dermatology|September 4, 2020
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trialA Blauvelt, C Leonardi, B Elewski, et al.
Techniques in Coloproctology|July 30, 2025
The application of EPSiT in pilonidal sinus disease: an international Delphi consensus study endorsed by the Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI)H K Sekhon Inderjit Singh, P Meinero, F C Campanile, et al.
Techniques in Coloproctology|August 19, 2023
Five-year recurrence after endoscopic approach to pilonidal sinus disease: A multicentre experienceM Manigrasso, A D'Amore, E Benatti, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 4, 2020
Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancerK G P Kerckhoffs, D H W Liu, L Saragoni, et al.
The Review of Scientific Instruments|March 5, 2008
A status report of the multipurpose superconducting electron cyclotron resonance ion sourceG Ciavola, S Gammino, S Barbarino, et al.
Pageof 48